Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in pharma

Pharmaceutical Industry – Poised For A Leap

The Indian pharma industry is at the crossroads of a revolutionary phase. The coming few years will see it grow exponentially in all aspects of the business

Read More

Cardiologist Deemed Covishield 'Worse In Cardiovascular Effects’

The Covid vaccine from Oxford/AstraZeneca is significantly worse than the mRNA jab from Pfizer in terms of cardiovascular effects, heart attacks, strokes and clotting issues in both younger and older adults, he said

Read More

Operating Income To Grow In 2023 Ahead Of Sandoz Spin Off: Novartis

Novartis said in its statement it's on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its focus on its patented prescription medicines

Read More

Gland Pharma’s Q3 PAT Slips 17% YoY

The company’s revenue from operations during the quarter has declined by 12 per cent at Rs 938.3 crore as compared to corresponding quarter of the previous year at Rs 1063.3 million

Read More

India Poised To Move From High-volume To High-value Products In Pharma: Mansukh Mandaviya

“The Government of India is committed to promoting Indian Life Sciences as a globally competitive sector to ensure the availability, accessibility, and affordability of drugs and medical devices in domestic and global markets,” said the minister

Read More

Gland Pharma International PTE To Acquire 100% Stake In Cenexi & Cenexi Holding Entities

The closing of the transaction is subject to customary closing conditions and receipt of the necessary regulatory approvals, stated the statement from Gland Pharma

Read More

6% Of Medicine Samples Of Substandard Quality In India

Furthermore, 50 (4 per cent) of 1,280 samples were again discovered to be of substandard quality in October

Read More

Merger: Advent To Purchase 50.1% Stake In India's Suven Pharma

Suven said Advent would make an additional open offer for up to 26 per cent of the voting share capital held by public shareholders at a price of 495 rupees per share. Shares rose as much as 4.8 per cent to 520 rupees in early trading

Read More

Roche's Lymphoma Therapy Receives Nod From USFDA

The U.S. Food and Drug Administration's approval for Lunsumio was based on an early-to mid-stage study that showed the drug cleared signs of cancer in patients, with most patients responding to the treatment for at least 18 months, the company said late Thursday

Read More

Alembic Gets USFDA Approval For Pregabalin Capsules

The approved sANDA is therapeutically equivalent to the reference listed drug product, Lyrica Capsules, of Upjohn. Pregabalin Capsules are indicated for neuropathic pain, postherpetic neuralgia, and other indications

Read More

Guerison Pharma To Enter India’s Ophthalmology Market

The company also introduced "Gueriherb", an immunity pill. Gueriherb is 100 per cent herbal, an immunity booster made from premium raw materials and has no side effects, it added

Read More

Glenmark Pharmaceuticals Receives USFDA Approval For Nicardipine Hydrochloride Capsules

According to IQVIATM sales data for the 12-month period ending October 2022, the Cardene Capsules, 20 mg and 30 mg market2 achieved annual sales of approximately USD 10.9 million, the statement by the company stated

Read More

GSK, Pfizer, Sanofi Evade Federal Litigation On Zantac

The ruling by U.S. District Judge Robin Rosenberg in West Palm Beach, Florida, knocks out about 50,000 claims in federal court, though it does not affect tens of thousands of similar cases pending in state courts around the country

Read More

Making Kerala A Pharma Hub: Pinarayi Vijayan

The CM underlined the importance of setting up ‘centres of excellence’ in emerging areas like genetic medicine, stem cell biology, medical imaging, bio-medical photonics, brain-computer interface, and genomics in medicine

Read More

Lupin Gets Tentative Nod From USFDA For Drospirenone Tablets

Drospirenone Tablets are a generic equivalent of Slynd Tablets, 4 mg, of Exeltis USA Inc and are used as a contraceptive medicine.

Read More